Limits...
The value of ultrasound-guided tattooing localization of nonpalpable breast lesions.

Ko K, Han BK, Jang KM, Choe YH, Shin JH, Yang JH, Nam SJ - Korean J Radiol (2007 Jul-Aug)

Bottom Line: The medical records associated with the US-tattoo, the pathology results and the follow-up US results were reviewed.The US-tattoo was well tolerated in all cases.The pathology result was benign in 108 cases, borderline in five, and malignant in 51.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiology and Center for Breast Cancer, National Cancer Center, Goyang-si 410-769, Korea.

ABSTRACT

Objective: To investigate the value of ultrasound-guided tattooing localization (US-tattoo) using a charcoal suspension for breast lesions.

Materials and methods: One hundred sixty-four nonpalpable breast lesions in 134 patients (mean age 47 years; range 30-74 years) were marked with a charcoal suspension under US guidance. The medical records associated with the US-tattoo, the pathology results and the follow-up US results were reviewed.

Results: The average size of the localized lesions was 1.0 cm. The procedure time was < 5 minutes (range, 2-10 minutes) per lesion. The US-tattoo was well tolerated in all cases. The only technical difficulty encountered was a needle tip blockage caused by a large charcoal particle (4.9%). The surgeon easily identified the tattoo with the exception one case. In addition, surgery could be safely delayed from one to 57 days after the making US-tattoo. The pathology result was benign in 108 cases, borderline in five, and malignant in 51. The excised specimen was < 4 cm in 76.6% (82/107) of the benign cases (mean; 2.7 cm). The pathologist could identify the mass around the tattoo and was able to make a specific diagnosis in 81.3% (87/107) of benign lesions. The only complication encountered was residual charcoal marking along the incision scar (3.6%). All follow-up US documented the removal of the lesions.

Conclusion: An US-tattoo for nonpalpable breast lesions is a very simple and accurate method that can help surgeons design and schedule an open biopsy.

Show MeSH

Related in: MedlinePlus

A 31-year-old woman presented for screening.A. Ultrasonogram shows a 1.3-cm-sized, complex cystic mass.B. Photomicrograph of the specimen after the US-tattoo shows a cystically dilated duct, containing charcoal (white arrows) and inflammatory exudates. (Hematoxylin & Eosin staining; original magnification, ×40)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2627157&req=5

Figure 2: A 31-year-old woman presented for screening.A. Ultrasonogram shows a 1.3-cm-sized, complex cystic mass.B. Photomicrograph of the specimen after the US-tattoo shows a cystically dilated duct, containing charcoal (white arrows) and inflammatory exudates. (Hematoxylin & Eosin staining; original magnification, ×40)

Mentions: The pathologist could easily identify the targeted lesion around the tattoo in all cases (Figs. 1, 2) except for one. Although the tumor area was partly masked by the tattoo, there was no significant interference with the pathological diagnosis. The pathology findings were benign lesions (n = 85), borderline lesions (n = 28) and malignant lesions (n = 51) (Table 4). The lesion size was 0.5-3.2 cm (mean size 1.0 cm) and the specimen size was 0.7-4 cm (mean size 2.7 cm).


The value of ultrasound-guided tattooing localization of nonpalpable breast lesions.

Ko K, Han BK, Jang KM, Choe YH, Shin JH, Yang JH, Nam SJ - Korean J Radiol (2007 Jul-Aug)

A 31-year-old woman presented for screening.A. Ultrasonogram shows a 1.3-cm-sized, complex cystic mass.B. Photomicrograph of the specimen after the US-tattoo shows a cystically dilated duct, containing charcoal (white arrows) and inflammatory exudates. (Hematoxylin & Eosin staining; original magnification, ×40)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2627157&req=5

Figure 2: A 31-year-old woman presented for screening.A. Ultrasonogram shows a 1.3-cm-sized, complex cystic mass.B. Photomicrograph of the specimen after the US-tattoo shows a cystically dilated duct, containing charcoal (white arrows) and inflammatory exudates. (Hematoxylin & Eosin staining; original magnification, ×40)
Mentions: The pathologist could easily identify the targeted lesion around the tattoo in all cases (Figs. 1, 2) except for one. Although the tumor area was partly masked by the tattoo, there was no significant interference with the pathological diagnosis. The pathology findings were benign lesions (n = 85), borderline lesions (n = 28) and malignant lesions (n = 51) (Table 4). The lesion size was 0.5-3.2 cm (mean size 1.0 cm) and the specimen size was 0.7-4 cm (mean size 2.7 cm).

Bottom Line: The medical records associated with the US-tattoo, the pathology results and the follow-up US results were reviewed.The US-tattoo was well tolerated in all cases.The pathology result was benign in 108 cases, borderline in five, and malignant in 51.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiology and Center for Breast Cancer, National Cancer Center, Goyang-si 410-769, Korea.

ABSTRACT

Objective: To investigate the value of ultrasound-guided tattooing localization (US-tattoo) using a charcoal suspension for breast lesions.

Materials and methods: One hundred sixty-four nonpalpable breast lesions in 134 patients (mean age 47 years; range 30-74 years) were marked with a charcoal suspension under US guidance. The medical records associated with the US-tattoo, the pathology results and the follow-up US results were reviewed.

Results: The average size of the localized lesions was 1.0 cm. The procedure time was < 5 minutes (range, 2-10 minutes) per lesion. The US-tattoo was well tolerated in all cases. The only technical difficulty encountered was a needle tip blockage caused by a large charcoal particle (4.9%). The surgeon easily identified the tattoo with the exception one case. In addition, surgery could be safely delayed from one to 57 days after the making US-tattoo. The pathology result was benign in 108 cases, borderline in five, and malignant in 51. The excised specimen was < 4 cm in 76.6% (82/107) of the benign cases (mean; 2.7 cm). The pathologist could identify the mass around the tattoo and was able to make a specific diagnosis in 81.3% (87/107) of benign lesions. The only complication encountered was residual charcoal marking along the incision scar (3.6%). All follow-up US documented the removal of the lesions.

Conclusion: An US-tattoo for nonpalpable breast lesions is a very simple and accurate method that can help surgeons design and schedule an open biopsy.

Show MeSH
Related in: MedlinePlus